Professional Documents
Culture Documents
Isolation of Ginkgolides A, B, C, J and Bilobalide From G. Biloba Extracts
Isolation of Ginkgolides A, B, C, J and Bilobalide From G. Biloba Extracts
Dedicated to Prof. Dr. Kurt Hostettmann on the occasion of his 60th birthday
Abstract
Ginkgolides A, B, C and J, together with bilobalide, are unique terpenoid components of the Ginkgo biloba tree. Due to similar
chemical properties, their separation is quite tedious. We have developed an efficient and rapid protocol for separation of individual
ginkgolides and bilobalide from G. biloba extracts. The procedure takes advantage of enhanced susceptibility of ginkgolides B and C
to benzylation and the ease of separation of these products from ginkgolides A and J which do not react. The protocol is applicable
to the previously reported enriched extracts prepared from G. biloba leaves. A single chromatographic step prior to benzylation pro-
vides bilobalide and mixture of ginkgolides A, B, C, and J. After benzylation, the individual ginkgolides are separated by
chromatography.
2004 Elsevier Ltd. All rights reserved.
0031-9422/$ - see front matter 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.phytochem.2004.08.026
2898 S. Jaracz et al. / Phytochemistry 65 (2004) 2897–2902
Table 1
Evaluation of different alkyl groups for selective monoetherification of GB (3) and GC (4)a
O R O
HO O O O
HO
10 R-Br, K2CO3 HO
10
O O O O
1 1
t-Bu DMF t-Bu
O O
R1 = -H (GB, 3) Me Me
HO HO
R1 = -OH (GC, 4) O O R1 O O R1
O O
O O HO O
10 10
R1 H2 (4 atm), 10% Pd/C HO
O O O O
1 1
t-Bu t-Bu
O EtOH O
Me Me
HO HO
O O R2 O O R2
R1 =- OH, R2 =- H (6) R2 =- H (3,G B)
R1 =R 2 =- OH (7) R2 =- OH (4,G C)
R1 =R 2 =- H (8)
a
Compound 8 -n or eaction.
Scheme 2. Hydrogenolysis of BnGB (6) and BnGC (7).a
HPLC, an aspect of particular importance for large-scale was loaded on a silica gel (100 g) column. The column
isolation of ginkgolides as phytopharmaceuticals. Fur- was slowly eluted with EtOAc/hexanes solvent mix-
thermore, BnGC (7) is an ideal precursor for a wide tures, first without external pressure then with slight
variety of transformations including the transformation external pressure. The initial solvent system was
into GB (3) (Corey et al., 1992; Jaracz et al., 2004; Teng, EtOAc/hexanes (3.5:6.5, 500 mL). Content of EtOAc
1992). in the eluent was increased gradually in six steps
(4:6, 500 mL; 4.5:5.5, 500 mL; 5:5, 500 mL; 5.5:4.5,
500 mL; 6:4, 400 mL; 6.5:3.5, 100 mL). The fractions
collected at EtOAc/hexanes (45:55) contained biloba-
4. Experimental
lide (0.4 g). The fractions collected at EtOAc/hexanes
(50:50) contained small amounts of impure BB (1) and
4.1. General experimental procedures
GA (2) then mixture GA/GB. The fractions collected
at EtOAc/hexanes (55:45) contained mixture GA/GB
All reagents were purchased and used as received.
(1.1 g). The fractions collected at EtOAc/hexanes
DMF was of reagent grade and used as received. Reac-
(40:60) contained mixture of GC/GJ (0.4 g) with small
tions and column chromatographies were monitored by
amount of GA (2) and GB (3).
analytical TLC (length = 33 mm) with silica gel 60 F254
and 1:1 EtOAc/hexanes mixture as the eluent. Spots were
visualized by heating and 254 nm irradiation. CC was 4.4. Purification of bilobalide
performed using silica gel (230–400 mesh). The ratio of
the column height and width was 5:1. 1H NMR spectra Bilobalide (310 mg) from the chromatography above
were recorded on Bruker (300, 400 or 500 MHz) spec- was suspended in Et2O (2 mL) diethyl ether, filtered and
trometers in DMSO-d6, methanol-d4 (native ginkgolides washed twice with Et2O (1 mL) to yield pure bilobalide
and bilobalide) and CDCl3 (ginkgolide derivatives). (217 mg purity by 1H NMR P 98%). 1H NMR and
Mass spectra were measured on JEOL JMS-HX110/ HRMS analytical data as previously reported (Nakani-
100A HF mass spectrometer under FAB conditions with shi et al., 1971).
NBA as the matrix. In general, all ginkgolides and their
derivatives decomposed above 250 C.
4.5. Benzylation of a ginkgolide A and B mixture
fied by flash column chromatography (30–50% EtOAc/ and the mixture was vigorously stirred under H2 (56
hexanes) to obtain BnGB (6) (326 mg) and GA (2) 134 psi, 3.8 atm). After 24 h, the reaction mixture was filtered
mg. GA (2) from the chromatography was further puri- through celite. Volatiles were removed under reduced
fied by recrystalization (EtOH/H2O or EtOAc/hexanes). pressure to obtain GB (257 mg) (3) as an off-white
1
H NMR and HRMS analytical data as previously re- crystalline powder (97% yield). 1H NMR and HRMS
ported for 2 (Llabres et al., 1989; van Beek and Lank- analytical data as previously reported (purity by 1H
horst, 1996) and 6 (Hu et al., 2000). NMR P 98%) (Llabres et al., 1989; van Beek and Lank-
BnGB (6). 1H NMR (300 MHz, CDCl3) d 7.46–7.28 horst, 1996).
(m, 5HAR), 5.98 (s, 1H, 12-H), 5.49 (d, J = 9.2 Hz, 1H,
benzylic), 5.31 (d, J = 3.1 Hz, 1H, 6-H), 4.90 (s, 1H, 4.8. Hydrogenolysis of 10-O-benzyl-ginkgolide C, 7
10-H), 4.59 (d, J = 9.2 Hz, 1H, benzylic), 4.53 (d,
J = 7.9 Hz, 1H, 2-H), 4.26 (dd, J = 7.9, 3.4 Hz, 1H, 1- To a solution of 7 (153 mg, 0.288 mmol) in EtOH (4
H), 3.05 (q, J = 7.0 Hz, 1H, 14-H), 2.80 (d, J = 3.4 Hz, mL) in a thick-wall flask was added 10% Pd/C (31 mg)
1H, 1-OH), 2.69 (s, 1H, 3-OH), 2.35–2.20 (m, 1H, 7- and the mixture was vigorously stirred under H2 (56
H), 2.00–1.88 (m, 2H, 7-H & 8-H), 1.30 (d, J = 7.0 Hz, psi, 3.8 atm). After 20 h, the reaction mixture was fil-
3H, 16-CH3), 1.15 (s, 9H, tBu); TLC: Rf = 0.68 (50% tered through celite. Volatiles were removed under re-
EtOAc/hexanes). duced pressure. The product was washed with EtOAc/
hexanes (15:85, 2 · 5 mL) to obtain (96% yield) GC
(4) 121.7 mg as a white powder. 1H NMR and HRMS
4.6. Benzylation of a ginkgolide A, B, C, and J mixture analytical data as previously reported (purity by 1H
NMR P 98%) (Llabres et al., 1989; van Beek and Lank-
To a ginkgolide mixture (543 mg, GA 3%, horst, 1996).
GB 4.5%, GC 68%, GJ 21% w/w, 0.92 mmol
of GB + GC) was added K2CO3 (1.27 g, 9.2 mmol,
10 eq.) and DMF (18 mL). While stirring using a Acknowledgements
magnetic stirrer, benzyl bromide (1.09 mL, 9.2 mmol,
10 eq.) was added. The mixture was stirred for 2 h We acknowledge the following for financial support:
then quenched with 1 M HCl (30 mL) and the solu- NIH Grant MH 068817, Memory Pharmaceuticals Inc.
tion was extracted with EtOAc (3·) and dried and the Alfred Bader Foundation (to S.J.). We are
(MgSO4). Volatiles were removed under reduced pres- grateful to Pharmanex for BioGinkgo 27/7, Dr. Dirk
sure and by multiple azeotropic evaporations with A. Lichtblau for preparation of enriched TTLs extract,
CHCl3. The mixture was purified by gradient CC Mr. Aaron Aylor for laboratory assistance, Professor
(30–60% EtOAc/hexanes) to obtain BnGB (6), (31.2 John M. Berger, Montclair State University, NJ, for dis-
mg) BnGC (7), (407.7 mg) of GA (2) (18.6 mg) and cussions, and Dr. Yasuhiro Itagaki for measurements of
ginkgolide J (111 mg) Ginkgolides A and J were fur- mass spectra.
ther purified by recrystalization from EtOH/H2O and/
or EtOAc/hexanes. 1H NMR and HRMS analytical
data as previously reported for 2, 5 (Llabres et al., References
1989; van Beek and Lankhorst, 1996), 6 (Hu et al.,
2000), and 7 (Vogensen et al., 2003). Braquet, P., 1987. The ginkgolides: potent platelet-activating factor
BnGC (7). 1H NMR (300 MHz, CDCl3) d 7.46–7.28 antagonists isolated from Ginkgo biloba leaves: chemistry, phar-
(m, 5HAR), 5.97 (s, 1H, 12-H), 5.46 (d, J = 9.2 Hz, 1H, macology and clinical applications. Drugs of the Future 12, 643–
benzylic), 5.11 (d, J = 4.4 Hz, 1H, 6-H), 4.93 (s, 1H, 699.
Camponovo, F.F., Wolfender, J.-L., Maillard, M.P., Potterat, O.,
10-H), 4.63 (d, J = 9.2 Hz, 1H, benzylic), 4.51 (d, Hostettmann, K., 1995. Evaporative light scattering and thermo-
J = 7.8 Hz, 1H, 2-H), 4.22 (dd, J = 7.8, 3.3 Hz, 1H, 1- spray mass spectrometry: two alternative methods for detection
H), 4.13 (ddd, J = 12.3, 11.5, 4.4 Hz, 1H, 7-H), 3.06 (q, and quantitative liquid chromatographic determination of ginkgo-
J = 7.0 Hz, 1H, 14-H), 3.04 (s, 1H, 3-OH), 2.82 (d, lides and bilobalide in Ginkgo biloba leaf extracts and phytophar-
J = 3.3 Hz, 1H, 1-OH), 2.35 (d, J = 11.5 Hz, 1H, 7- maceuticals. Phytochem. Anal. 6, 141–148.
Chandrasekaran, K., Mehrabian, Z., Spinnewyn, B., Drieu, K.,
OH), 1.70 (d, J = 12.3 Hz, 1H, 8-H), 1.30 (d, J = 7.0 Fiskum, G., 2001. Neuroprotective effects of bilobalide, a compo-
Hz, 3H, 16-CH3), 1.23 (s, 9H, tBu); TLC: Rf = 0.44 nent of the Ginkgo biloba extract (EGb 761), in gerbil global brain
(50% EtOAc/hexanes). ischemia. Brain Res. 922, 282–292.
Choi, Y.H., Kim, J., Yoo, K.-P., 2002. Supercritical-fluid extraction of
4.7. Hydrogenolysis of 10-O-benzyl-ginkgolide B, 6 bilobalide and ginkgolides from Ginkgo biloba leaves by use of a
mixture of carbon dioxide, methanol, and water. Chromatographia
56, 753–757.
To a solution of 6 (322 mg, 0.626 mmol) in EtOH (5 Corey, E.J., Rao, K.S., Ghosh, A.K., 1992. Intramolecular and
mL) in a thick-wall flask was added 10% Pd/C (64 mg) intermolecular hydroxyl reactivity differences in ginkgolides A, B
2902 S. Jaracz et al. / Phytochemistry 65 (2004) 2897–2902
and C and their chemical applications. Tetrahedron Letters 33, Okabe, K., Yamada, K., Yamamura, S., Takada, S., 1967. Ginkgo-
6955–6958. lides. Journal of the Chemical Society C, 2201–2206.
Drieu, K., Jaggy, H., 2000. History, development and constituents of OÕReilly, J., 2000. Ginkgo biloba – large scale extraction and process-
EGb 761. In: van Beek, T.A. (Ed.), Ginkgo Biloba, vol. 12. ing. In: van Beek, T.A. (Ed.), Ginkgo Biloba, vol. 12. Harwood
Harwood Academic Publishers, Amsterdam, pp. 267–277. Academic Publishers, Amsterdam, pp. 99–108.
Hu, L., Chen, Z., Xie, Y., Jiang, H., Zhen, H., 2000. Alkyl and Schmid, W., 1997. Ginkgo thrives. Nature 386, 755.
alkoxycarbonyl derivatives of ginkgolide B: synthesis and biolog- Strømgaard, K., Nakanishi, K., 2004. Chemistry and biology of
ical evaluation of PAF inhibitory activity. Bioorg. Med. Chem. 8, terpene trilactones from Ginkgo biloba. Angewandte Chemie
1515–1521. International Edition 43, 1640–1658.
Ivic, L., Sands, T.T.J., Fishkin, N., Nakanishi, K., Kriegstein, A.R., Teng, B.P., 1988. Chemistry of ginkgolides. In: Braquet, P. (Ed.),
Strømgaard, K., 2003. Terpene trilactones from Ginkgo biloba are Ginkgolides - Chemistry, Biology, Pharmacology and Clinical
potent antagonists of glycine and GABAA receptors. Journal of Perspectives. J.R. Prous Science Publishers, S.A., Barcelona, pp.
Biological Chemistry 278, 49279–49285. 37–42.
Janssens, D., Remacle, J., Drieu, K., Michiels, C., 1999. Protection of Teng, B.P., 1992. Preparation of ginkgolide B from ginkgolide C. Ger.
mitochondrial respiration activity by bilobalide. Biochemical Offen., Patent Number: 4212019.
Pharmacology 58, 109–119. Teng, B.-P., 2002. Method for preparing an extract of Ginkgo biloba
Jaracz, S., Nakanishi, K., Jensen, A.A., Strømgaard, K., 2004. leaves highly enriched in active principles. PCT Int. Appl. Patent
Ginkgolides and glycine receptors: a structure–activity relationship Number: 0283158.
study. Chemistry- A European Journal 10, 1507–1518. van Beek, T.A., Lankhorst, P.P., 1996. Confirmation of the C-1
Kondratskaya, E.L., Krishtal, O.A., 2002. Effects of Ginkgo biloba stereochemistry of ginkgolides by NMR. Tetrahedron 52, 4505–
extract constituents on glycine-activated strychnine-sensitive recep- 4514.
tors in hippocampal pyramidal neurons of the rat. Neurophysiol- van Beek, T.A., Lelyveld, G.P., 1997. Preparative isolation and
ogy (Trans. Neirofiziologiya) 34, 155–157. separation procedure for ginkgolides A, B, C, and J and bilobalide.
Lichtblau, D., Berger, J.M., Nakanishi, K., 2002. Efficient extraction Journal of Natural Products 60, 735–738.
of ginkgolides and bilobalide from Ginkgo biloba leaves. Journal of van Beek, T.A., Taylor, L.T., 1996. Sample preparation of standard-
Natural Products 65, 1501–1504. ized extracts of Ginkgo biloba by supercritical fluid extraction.
Llabres, G., Baiwir, M., Sbit, M., Dupont, L., 1989. Ginkgolides A, B Phytochemical Analysis 7, 185–191.
and C: a 1D and 2D NMR study. Spectrochimica Acta 45A, 1037– Vogensen, S.B., Stromgaard, K., Shindou, H., Jaracz, S., Suehiro, M.,
1045. Ishii, S., Shimizu, T., Nakanishi, K., 2003. Preparation of 7-
Lobstein-Guth, A., Briancon-Scheid, F., Anton, R., 1983. Analysis of substituted ginkgolide derivatives: potent platelet activating factor
terpenes from Ginkgo biloba leaves by high-performance liquid (PAF) receptor antagonists. Journal of Medical Chemistry 46, 601–
chromatography. Journal of Chromatography 267, 431–438. 608.
Maclennan, K.M., Darlington, C.L., Smith, P.F., 2002. The CNS Wada, K., Sasaki, K., Miura, K., Yagi, M., Kubota, Y., Matsumoto,
effects of Ginkgo biloba extracts and ginkgolide B. Progress in T., Haga, M., 1993. Isolation of bilobalide and ginkgolide A from
Neurobiology 67, 235–257. Ginkgo biloba L. shorten the sleeping time induced in mice by
Maruyama, M., Terahara, A., Nakadaira, Y., Woods, M.C., Nakan- anesthetics. Biological and Pharmaceutical Bulletin 16, 210–212.
ishi, K., 1967a. The ginkgolides IV. Stereochemistry of the Wai, C.M., Lang, Q., 2003. Pressurized water extraction of bilobalides
ginkgolides. Tetrahedron Letters 4, 315–319. and ginkgolides from Ginkgo. US patent, Patent Number:
Maruyama, M., Terahara, A., Itagaki, Y., Nakanishi, K., 1967b. The 6524628.
ginkgolides I. Isolation and characterization of the various groups. Weinges, K., Bähr, W., 1972. NMR- and massenspektrometrischer
Tetrahedron Letters 4, 299–302. vergleichdes bilobalids C15H18O8 mit den ginkgoliden C20H24O9–11.
Nakanishi, K., 1967. The ginkgolides. Pure and Applied Chemistry 14, Liebigs Annalen der Chemie 759, 158–172.
89–113. Weinges, K., Hepp, M., Jaggy, H., 1987. Chemie der ginkgolide, II.
Nakanishi, K., Habaguchi, K., Nakadaira, Y., Woods, M.C., Maruy- Isolierung und strukturaufklärung eines neuen ginkgolids. Liebigs
ama, M., Major, R.T., Alauddin, M., Patel, A.R., Weinges, K., Annalen der Chemie, 521–526.
Bähr, W., 1971. Structure of bilobalide, a rare tert-butyl containing Zhou, L.-J., Zhu, X.-Z., 2000. Reactive oxygen species-induced
seuqiterpenoid related to the C20-ginkgolides. Journal of the apoptosis in PC12 cells and protective effect of bilobalide. Journal
American Chemical Society 93, 3544–3546. of Pharmacology and Experimental Therapeutics 293, 982–988.